‘Let The Good Times Roll Again’: VCs Confident in Biotech Activity for ’24

Several experts on a panel Wednesday at JPM’s Biotech Showcase expressed positive attitudes for the coming year on the investment side, with Andrew Lam, the principal of special investments at Ally Bridge Group, commenting that the panel’s title should be “Biotech in 2024: Let the good times roll.”